Segment Information and Concentrations (Tables)

9 Months Ended

12 Months Ended

Mar. 31, 2021

Jun. 30, 2020

Segment Reporting [Abstract]

Segment information

	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Three Months Ended March 31, 2021:
Revenues	$	2,365,700	$	142,900		$	-		$	2,508,600
Foreign Sales		942,200		102,600					1,044,800
Income (Loss) From Operations		774,600		(1,722,200	)		(911,200	)		(1,858,800	)
Assets		5,979,400		1,281,200			6,639,700			13,900,300
Long-Lived Asset Expenditures		18,600		92,100			-			110,700
Depreciation and Amortization		30,000		16,700			-			43,700

	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Three Months Ended March 31, 2020:
Revenues	$	1,800,700	$	335,500		$	-		$	2,136,200
Foreign Sales		743,000		335,000			-			1,078,000
Income (Loss) From Operations		138,800		(193,100	)		(180,700	)		(235,000	)
Assets		5,229,700		1,647,800			2,042,400			8,919,900
Long-Lived Asset Expenditures		4,900		11,700			-			16,600
Depreciation and Amortization		29,600		11,000			300			40,900

	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Nine Months Ended March 31, 2021:
Revenues	$	6,803,300	$	441,800		$	-		$	7,245,100
Foreign Sales		2,724,800		395,000			-			3,119,800
Income (Loss) From Operations		1,727,000		(2,996,300	)		(1,029,600	)		(2,298,900	)
Assets		5,979,400		1,281,200			6,639,700			13,900,300
Long-Lived Asset Expenditures		54,100		170,800			-			224,900
Depreciation and Amortization		79,700		46,500			500			126,700

	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Nine Months Ended March 31, 2020:
Revenues	$	5,320,300	$	914,200		$	-		$	6,234,500
Foreign Sales		1,996,400		913,700			-			2,910,100
Income (Loss) From Operations		331,300		(209,400	)		(180,700	)		(58,800	)
Assets		5,229,700		1,647,800			2,042,400			8,919,900
Long-Lived Asset Expenditures		26,800		31,300			-			58,100
Depreciation and Amortization		90,900		31,500			900			123,300

	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2020:
Revenues	$	6,783,600	$	1,000,800		$	-		$	7,784,400
Foreign Sales		2,589,800		1,000,400			586,500			4,176,700
Income (Loss) From Operations		449,700		(727,500	)		(385,700	)		(663,500	)
Assets		12,232,600		546,100			2,018,700			14,797,400
Long-Lived Asset Expenditures		36,000		40,700			-			76,700
Depreciation and Amortization		116,900		42,700			1,300			160,900

	Benchtop Laboratory Equipment		Bioprocessing Systems		Corporate and Other		Consolidated
June 30, 2019:
Revenues	$	7,078,800	$	1,306,100	$	-	$	8,384,900
Foreign Sales		2,680,300	$	1,301,200		1,102,300		5,083,800
Income (Loss) From Operations		449,800		365,000		91,900		906,700
Assets		5,280,700		790,100		2,205,200		8,276,000
Long-Lived Asset Expenditures		194,500		15,700		2,200		212,400
Depreciation and Amortization		217,800		38,500		1,000		257,300